Cerenome (PSTV) Amortization of Deferred Charges (2010 - 2026)
Plus Therapeutics (PSTV) posted quarterly Amortization of Deferred Charges of $13000.0 for Q1 2026, down 62.86% year-over-year from $35000.0 in Q1 2025, and up 44.44% quarter-over-quarter from $9000.0 in Q3 2025.
Cerenome (PSTV) Amortization of Deferred Charges (2010 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has reported Amortization of Deferred Charges for 17 consecutive years, with $13000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortization of Deferred Charges fell 62.86% year-over-year to $13000.0; the TTM figure through Mar 2026 stood at $66000.0 (up 69.23% YoY), while the FY2024 annual figure was $20000.0, down 82.91% from the prior year.
- Amortization of Deferred Charges advanced to $13000.0 in Q1 2026 per PSTV's latest filing, from $9000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $115000.0 in Q1 2022 and bottomed at -$76000.0 in Q4 2024.
- Historically, Amortization of Deferred Charges has averaged $37000.0 across 5 years, with a median of $34000.0 in 2024.
- On a YoY basis, Amortization of Deferred Charges climbed as much as 200.0% in 2024 and fell as far as 345.16% in 2024.
- Plus Therapeutics' Amortization of Deferred Charges stood at $80000.0 in 2022, then tumbled by 61.25% to $31000.0 in 2023, then tumbled by 345.16% to -$76000.0 in 2024, then jumped by 111.84% to $9000.0 in 2025, then surged by 44.44% to $13000.0 in 2026.
- Business Quant data shows PSTV's Amortization of Deferred Charges at $13000.0 in Q1 2026, $9000.0 in Q3 2025, and $9000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,000.00 |
| Mar 31, 2026 | 13,000.00 |
| Sep 30, 2025 | 9,000.00 |
| Sep 30, 2025 | 9,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | -76,000.00 |
| Dec 31, 2024 | -76,000.00 |
| Sep 30, 2024 | 33,000.00 |
| Sep 30, 2024 | 33,000.00 |
| Jun 30, 2024 | 47,000.00 |
| Jun 30, 2024 | 47,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Dec 31, 2023 | 31,000.00 |
| Dec 31, 2023 | 31,000.00 |
| Sep 30, 2023 | -33,000.00 |
| Sep 30, 2023 | -33,000.00 |